# Appropriate Management of Hepatic EncePhalopaThy AmonG cirrhOtic patieNts Admitted to Internal Medicine

> **NCT07727070** · — · ACTIVE_NOT_RECRUITING · sponsor: **Fadoi Foundation, Italy** · enrollment: 400 (estimated)

## Conditions studied

- Cirrhoses, Liver
- Portal Hypertension Related to Cirrhosis
- Liver Stiffness
- Hepatic Encephalopathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07727070
- **Lead sponsor:** Fadoi Foundation, Italy
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-12-05
- **Primary completion:** 2026-12
- **Final completion:** 2027-08
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07727070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07727070, "Appropriate Management of Hepatic EncePhalopaThy AmonG cirrhOtic patieNts Admitted to Internal Medicine". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07727070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*